Current Issues in Clinical Research and the Development of New Pharmaceuticals
Accountability in Research 2001; 8(4): 283-291
As a normal part of the drug development process, U.S. pharmaceutical companies conduct many thousands of clinical trials each year. Only after a reasonable assurance of safety is made can the drug be given to patients who have the underlying medical condition that the drug is designed to treat. Patient welfare is assured by adhering to the Food and Drug Administration's interpretation of the "common rule" if the data will be used to support a licensing application. 21 CFR Part 50 sets forth the regulations along with the principles of informed consent and the use of institutional review boards (IRBs) that assure patients' rights are protected. Any potential conflict of interest on the part of a clinical investigator must be reported to the FDA. Pharmaceutical companies extensively monitor ongoing clinical trials for compliance with appropriate regulations. The recent revision of the Declaration of Helsinki governing placebo- controlled clinical trials may adversely impact drug development.
Clinical Trials; Conflict of Interest; Controlled Clinical Trials; Clinical Research; Consent; Food; Informed Consent; Institutional Review Boards; Patients; Patients' Rights; Research; Review; Rights; Drugs and Drug Industry; Human Experimentation Policy Guidelines / Institutional Review Boards; Informed Consent or Human Experimentation; Social Control of Human Experimentation;
Showing items related by title, author, creator and subject.
Frontline Ethical Issues in Pediatric Clinical Research: Ethical and Regulatory Aspects of Seven Current Bottlenecks in Pediatric Clinical Research Pinxten, Wim; Nys, Herman; Dierickx, Kris (2010-12)In the course of the past decades, considerable effort has been expended on the ethical guidance and legal regulation of pediatric clinical trials in Europe. Nonetheless, the conduct of clinical research in the population ...
Domestic and Multinational Clinical Trials: Issues in Design, Implementation, and Management for Biotechnology Research and Product Development Fishbein, Jonathan M.; Grignolo, Alberto; Lund, Marcia (1998-12)